For as long as medicine has existed, cancers have ravaged humanity. The search for an eventual cure has been a tremendous & tireless pursuit, selflessly undertaken by doctors, researchers, scientists & the entire healthcare community. With each passing year and the availability of sophisticated technologies, their efforts continue to go from strength to strength, expanding our means to adequately cope, manage and possibly rebuff the disease which has so often reminded us of our mortality. Up until recently, Chemotherapy, Surgeries, Radiation & Targeted Drug therapies had been the go-to for…
Read MoreTag: CAR-T Cells
Speaker Interview with Fabio D’Agostino for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress
London, January 07 – MarketsandMarkets interviewed Fabio D’Agostino,Venture Partner, Claris Ventures regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Q. What is the most trending areas of cellular therapies currently? A. CART and NK cell Q. What are the recent developments and technological advancements? A. CART for solid tumors and NK CAR Q. What are the key take away points from your presentation? A. They are basically summarized in my bullet points. I will…
Read MoreWhat do MNM Analysts have to say about the Immuno Oncology Market?
Our 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress to be held on 12th-13th March 2020 in London, UK would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes, pharmaceutical, bio-pharmaceutical, and biotechnology companies to discuss the latest updates in the development of ADC’s, Bispecific Antibodies, Cellular Therapy, and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case…
Read More